DiaMedica Therapeutics
DMAC | NASDAQ
$8.33
-$0.46 (-5.23%)
At close: Nov 16, 2026, 4:00 PM ET
$8.33
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
DiaMedica Therapeutics Institutional Ownership
Institutional ownership explainedInstitutional Ownership
Net InflowTotal Institutions
92
Total Ownership
23.45%
Capital Flow
+$9.34M
Shares Change
+870.91K
Ownership Distribution
Institutions (23.45%)
Others (76.55%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
13
Increased Positions
45
Reduced Positions
20
Closed Positions
21
New (13)
Increased (45)
Reduced (20)
Closed (21)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| NewEdge Wealth | 6.40% +70.79% | 1.09% | 3.45M | 27.74M | |
| Private Capital Management LLC | 0.09% 0.00% | 0.04% | 50K | 402K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Cooperman Leon G | 6.40% +70.47% | 0.68% +52.60% | 3.45M +70.79% | 24.29M +77.60% | |
| Blackrock, Inc. | 4.18% +21.11% | < 0.01% +7.32% | 2.25M +21.34% | 15.86M +26.18% | |
| Geode Capital Management, LLC | 1.66% +14.34% | < 0.01% +2.11% | 894.12K +14.55% | 6.3M +19.12% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove DMAC